BHV-7000 Acute Treatment of Bipolar Mania

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Bipolar Disorder

In brief

The purpose of this study is to determine whether BHV-7000 is a safe and effective acute treatment for manic episodes in bipolar disorder I.

Key facts

Study ID
NCT06419582
Run by
Biohaven Therapeutics Ltd.
People needed
274
Starts
2024-05-28
Expected to finish
2025-01-30
Last updated by the study team
2025-12-16

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.